Global Glycated Hemoglobin Testing Market Growth (Status and Outlook) 2023-2029

Global Glycated Hemoglobin Testing Market Growth (Status and Outlook) 2023-2029

Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since red blood cells do not all undergo lysis at the same time, HbA1C is taken as a limited measure of three months. It is formed in a non-enzymatic glycation pathway by hemoglobin's exposure to plasma glucose.

LPI (LP Information)' newest research report, the “Glycated Hemoglobin Testing Industry Forecast” looks at past sales and reviews total world Glycated Hemoglobin Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Glycated Hemoglobin Testing sales for 2023 through 2029. With Glycated Hemoglobin Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glycated Hemoglobin Testing industry.

This Insight Report provides a comprehensive analysis of the global Glycated Hemoglobin Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glycated Hemoglobin Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glycated Hemoglobin Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glycated Hemoglobin Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glycated Hemoglobin Testing.

The global Glycated Hemoglobin Testing market size is projected to grow from US$ 293.3 million in 2022 to US$ 479.1 million in 2029; it is expected to grow at a CAGR of 7.3% from 2023 to 2029.

High prevalence rate coupled with increasing incidence of diabetes among individuals in developed and developing economies are major factors driving growth of the global glycated hemoglobin testing market. In addition, growing awareness among diabetics for early diagnosis of diabetes so as to help in treatment & management of diabetes is another factor fueling growth of the global glycated hemoglobin testing market.

This report presents a comprehensive overview, market shares, and growth opportunities of Glycated Hemoglobin Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Lab Based Test
Point-of-Care Test

Segmentation by application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bio-Rad Laboratories
Danaher
EKF Diagnostics
F. Hoffmann-La Roche

Please note: The report will take approximately 2 business days to prepare and deliver.